Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.8250 (-4.61%) ($12.7700 - $12.8250) on Thu. Sep. 15, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.17% (three month average) | RSI | 25 | Latest Price | $12.8250(-4.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(33%) VT(32%) VUG(32%) URA(31%) BLOK(30%) | Factors Impacting BCRX price | BCRX will decline at least -2.085% in a week (0% probabilities). VIXM(-15%) UUP(-14%) SMH(-11%) VXX(-3%) EDOC(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.085% (StdDev 4.17%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $6.8(-46.98%) | Resistance Level | $13.89 | 5 Day Moving Average | $13.33(-3.79%) | 10 Day Moving Average | $13.56(-5.42%) | 20 Day Moving Average | $13.89(-7.67%) | To recent high | -13.5% | To recent low | 41.2% | Market Cap | $2.263b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |